Literature DB >> 13496234

Cycloserine in the treatment of pulmonary tuberculosis; a report on toxicity.

W C WALKER, J M MURDOCH.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS/therapeutic use; TUBERCULOSIS, PULMONARY/therapy

Mesh:

Substances:

Year:  1957        PMID: 13496234     DOI: 10.1016/s0041-3879(57)80097-x

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


× No keyword cloud information.
  10 in total

1.  ACUTE POISONING BY CYCLOSERINE.

Authors:  R ATKINS; C J CUTTING; T F MACKINTOSH
Journal:  Br Med J       Date:  1965-04-03

2.  PSYCHOSIS ASSOCIATED WITH CYCLOSERINE.

Authors:  R G BANKIER
Journal:  Can Med Assoc J       Date:  1965-07-03       Impact factor: 8.262

3.  Reducing the toxicity of tubazid by administering it in combination with cycloserine.

Authors:  N I SMOL'NIKOVA
Journal:  Biull Eksp Biol Med       Date:  1962-02

4.  Cycloserine in treatment of infection of urinary tract.

Authors:  J M MURDOCH; J D SLEIGH; S C FRAZER
Journal:  Br Med J       Date:  1959-11-21

5.  Intra-hippocampal D-cycloserine rescues decreased social memory, spatial learning reversal, and synaptophysin levels in aged rats.

Authors:  Marta Portero-Tresserra; Margarita Martí-Nicolovius; Mireia Tarrés-Gatius; Ana Candalija; Gemma Guillazo-Blanch; Anna Vale-Martínez
Journal:  Psychopharmacology (Berl)       Date:  2018-02-28       Impact factor: 4.530

Review 6.  Drug-induced psychiatric disorders.

Authors:  D A Johnson
Journal:  Drugs       Date:  1981-07       Impact factor: 9.546

Review 7.  Neurological manifestations and toxicities of the antituberculosis drugs. A review.

Authors:  M R Holdiness
Journal:  Med Toxicol       Date:  1987 Jan-Feb

8.  Pharmacological modulation of the short-lasting effects of antagonistic direct current-stimulation over the human motor cortex.

Authors:  Leila Chaieb; A Antal; D Terney; W Paulus
Journal:  Front Psychiatry       Date:  2012-07-05       Impact factor: 4.157

9.  Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis.

Authors:  Wael A Alghamdi; Abdullah Alsultan; Mohammad H Al-Shaer; Guohua An; Shahriar Ahmed; Yosra Alkabab; Sayera Banu; Ketevan Barbakadze; Eric Houpt; Maia Kipiani; Lali Mikiashvili; Stephan Schmidt; Scott K Heysell; Russell R Kempker; J Peter Cegielski; Charles A Peloquin
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

10.  High Incidence of Psychiatric Disorders Associated with Cycloserine Treatment of Multidrug-Resistant Tuberculosis Patients: A Cohort Study in Beijing, China.

Authors:  Yu Pang; Rongmei Liu; Yanhua Song; Zizheng Lv; Mengqiu Gao; Lihui Nie; Qiping Ge; Xiaoguang Wu
Journal:  Infect Drug Resist       Date:  2022-07-13       Impact factor: 4.177

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.